WHO declares monkeypox a public health emergency of international concern (PHEIC)

7/23/22

HHS extends COVID-19 public health emergency again

7/15/22

FDA authorizes Novavax protein subunit COVID-19 vaccine for those 18 and older

7/13/22

FDA recommends repeat dosing for Evusheld every six months

6/29/22

FDA extends Evusheld shelf life from 18 to 24 months

6/28/22

FDA expands authorization of Pfizer/BioNTech and Moderna vaccines to those ages 6 months to 4 years old

6/17/22

CDC recommended Pfizer COVID-19 vaccine booster shots for those ages 5-11

5/19/22

FDA authorizes mail-in, non-prescription test for influenza, SARS-CoV-2, and RSV

5/16/22

Safety and efficacy of SARS-CoV-2 vaccination in the immunocompromised

5/12/22

FDA Q&A provides information on Paxlovid

5/4/22

COVID-19 Public Health Emergency renewed for 90 days

4/12/22

Sotrovimab no longer authorized in U.S. due to rise of Omicron sub-variant BA.2

4/5/22

ASPR launches COVID-19 Test to Treat locator tool

3/31/22

Researchers announce use of COVID-19 vaccine to treat chronic SARS-CoV-2 infection

3/21/22

Congress extends pandemic telehealth flexibilities in FY 2022 spending bill

3/15/22

CDC announces new metrics for gauging COVID-19 risk and guiding mitigation strategies like masking

2/25/22

FDA doubles recommended dose of Evusheld for COVID-19 prevention

2/24/22

Federal government purchases additional doses of COVID-19 preventative Evusheld

2/14/22

FDA authorizes monoclonal antibody bebtelovimab for treatment of COVID-19 in high-risk patients

2/11/22

CDC recommends COVID-19 booster three months from primary mRNA vaccine series for immunocompromised

2/11/22

FDA amends authorizations for an additional COVID-19 mRNA vaccine dose for immunocompromised

8/13/21